P

Premier Research International

Contract research organization for clinical development

Regulatory Submissions Lead 2

Full-TimeUpdated
No salary listed
Senior, Expert
Bachelor's
Remote in Argentina
Remote
Biology & BiotechRegulatory & Quality (Life Sciences)

About the job

Requirements
  • Education to university degree level; pharmacy, medicine, or related natural sciences are a plus.
  • Hands-on experience with European Union Clinical Trial Information System Part I submissions, United States Institutional Review Board oversight, and Argentine submission processes.
  • Eight to ten years of experience, including at least six years as a Regulatory Submissions Lead, Start-Up Lead, Submissions Manager, or equivalent.
  • Experience managing submissions for complex trials, different investigational product types and phases, globally.
  • Excellent knowledge of International Council for Harmonisation/Good Clinical Practice regulations and applicable country-specific regulations.
  • Excellent knowledge of Food and Drug Administration guidance documents, European Union regulations, International Organization for Standardization 14155 regulations, drug and device development, and start-up procedures.
  • Ability to multitask and work effectively in a fast-paced environment with changing priorities.
  • Excellent organizational and time-management skills, with the ability to prioritize work to meet deadlines.
  • Accountability, dependability, and a strong commitment to quality.
  • A customer-service-focused approach to internal and external work.
Responsibilities
  • Lead and execute regulatory strategy, submissions, and approvals across participating countries throughout the study lifecycle by developing and managing regulatory and start-up project plans; coordinating and submitting Clinical Trial Applications to applicable regulatory bodies, import/export licenses, and other regulatory applications for multi-region and complex studies in start-up.
  • For maintenance studies, ensure timely submission of substantial and non-substantial modifications and required trial notifications, including first patient in, end of trial, temporary halts, and early terminations through Clinical Study Reports.
  • For European Union interventional clinical studies, lead and execute activities in the Clinical Trial Information System, own the overall regulatory submission strategy, and prepare and complete Part I.
  • Act as the primary regulatory and submissions lead for sponsors and project teams, ensuring alignment on timelines, deliverables, submission strategies, document readiness, and regulatory requirements.
  • Identify, communicate, and manage risks, issues, and contingency plans; escalate critical concerns; recommend resolutions; and lead regulatory and submission-related discussions during kick-off meetings and internal and external study calls.
  • Prepare, review, and secure sponsor approval of core submission documents, including application forms, cover letters, Patient Information Sheets/Informed Consent Forms, import/export applications, and country-specific submission packages.
  • Review essential clinical and regulatory documents, including Investigational Medicinal Product Dossiers, protocols, Investigator's Brochures, master and country informed consent forms, investigational product labels, and other regulatory materials, to ensure compliance, completeness, quality, and country-specific acceptability.
  • Define and agree Greenlight Package templates with sponsors, coordinate completion of country and site greenlight packages with Study Start-Up Associates, and support country and site activation strategies with other functional areas.
  • Ensure high-quality execution of regulatory and start-up activities, stay current with evolving regulations and guidance, support continuous process improvement, monitor study start-up budgets and contractual obligations, and identify out-of-scope functional activities.
  • Serve as a subject matter expert in specialized areas and complex studies such as genetically modified organisms and MedTech; coach, mentor, supervise, and train junior staff; lead departmental improvement initiatives; and contribute to business development through client meetings, bid defenses, design presentations, and strategic regulatory input during proposal development.
Desired Qualifications
  • Experience in Medical Device Regulation/In Vitro Diagnostic Regulation and genetically modified organisms is highly recommended.
  • Ability to work collaboratively and build an effective team.

About the company

P

Premier Research International

View

Premier Research provides specialized clinical development services for biotech and specialty pharma, focusing on specific therapeutic areas where science is advancing. It supports end-to-end clinical trials, including study design, site management, data handling, statistics, regulatory affairs, and medical writing, across more than 20 countries with about 1,500 employees. Customers partner with Premier Research to plan and run development programs with cross-functional teams that design trials, manage sites and data, analyze results, and prepare regulatory submissions. The company aims to help biotech and pharma bring safe, effective therapies to patients faster by delivering high-quality clinical development and regulatory support.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$79.2M

Headquarters

Morrisville, North Carolina

Founded

1989

Get referred to Premier Research International

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Premier extended Daré Bioscience exclusivity in 2026 for U.S. reproductive-health CRO services.
  • Its January 2024 BioCentriq partnership targets faster pre-IND cell therapy timelines.
  • ASCO 2026 highlighted Premier Applied Sciences' myeloma study with Mango Sciences, strengthening credibility.

What critics are saying

  • Indeed rated Premier Research 2.6/5 for job security and advancement in May 2026.
  • Glassdoor reviews cite weak training, overtime, and low trust in upper management.
  • Frequent executive turnover since 2024 signals integration strain if sponsor growth stalls in 2026-2027.

What makes Premier Research International unique

  • Premier Research specializes in biotech, specialty pharma, and medtech, not broad-market CRO work.
  • Its 2026 leadership hires target commercial scale and operational quality, including Paul Spreen and Siân Smethurst.
  • Premier combines clinical execution with regulatory strategy and product development across 20-plus countries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

16%
PR Newswire
Apr 7th, 2026
Premier Research appoints Paul Spreen as chief commercial officer

Premier Research, a global clinical research and product development company, has appointed Paul Spreen as Chief Commercial Officer. Spreen brings over 25 years of life sciences leadership experience and will oversee global commercial strategy, business development, marketing and proposals. Spreen previously served as EVP and Chief Commercial Officer at IQVIA (formerly Quintiles), where he held several global leadership positions. His experience spans the full drug development lifecycle, from early discovery through commercialisation, with a focus on scaling organisations during periods of rapid growth and M&A. In his new role, Spreen will drive sustainable growth, strengthen customer engagement and advance Premier's position across the drug development spectrum. The Morrisville, North Carolina-based company specialises in clinical trials and regulatory strategy for the biotechnology sector.

PharmiWeb
Apr 2nd, 2025
Premier Research Expands Clinical Leadership Team With Addition Of Milena Kanova-Petrova, Md, Global Head Of General Medicine

MORRISVILLE, NC, April 1, 2024 – Premier Research is pleased to announce the addition of Dr. Milena Kanova-Petrova as Senior Vice President, Global Head of General Medicine. In this role, Dr. Kanova-Petrova will oversee strategic planning and project execution for all general medicine clinical operations inclusive of internal medicine, women’s health and dermatology.“Our customers are breaking barriers and forging new pathways every day in the pursuit of bettering patient care. The work is complex and specialized, and adding Dr. Kanova-Petrova to our Clinical Leadership Team expands the specialization that we can provide to our customers,” said Premier Research Chief Operating Officer, Michael Arlotto, Ph.D

Labiotech
Jun 13th, 2024
From Ai To Telemedicine: Transforming Clinical Trial Recruitment In 2024

Recruitment is essential for generating data on drug efficacy, which is crucial for the approval of new medical treatments. Clinical trial success hinges on the ability to recruit a sufficient and appropriate number of participants. As Cara Brant, chief executive officer (CEO) of Clinical Trial Media puts it, “Trials are intended to generate data on how a drug works and you can’t generate that data if you don’t have participants in the study. This makes recruitment one of the linchpins of clinical research and drug development as a whole.”However, the landscape of clinical trial recruitment is becoming increasingly competitive. With over 450,000 clinical trials in progress globally, according to Brant. The task of recruiting participants has never been more challenging​​

TrialHub
Jan 31st, 2024
Shaping Patient-Centric Healthcare: Premier Research Collaborates with FindMeCure's TrialHub to Educate Patients About Clinical Research

TrialHub, a leading platform for patient feasibility in clinical trials, is proud to announce its collaboration with Premier Research.

PR Newswire
Jan 8th, 2024
Premier Research And Biocentriq Enter A Strategic Partnership To Accelerate Pre-Ind Timelines And Clinical Translation Of Innovative Cell Therapies

MORRISVILLE, N.C. and NEWARK, N.J., Jan. 8, 2024 /PRNewswire/ -- Premier Research, a preeminent global clinical research, product development, and consulting company, and BioCentriq, a renowned Contract Development and Manufacturing Organization (CDMO), have entered a strategic partnership to revolutionize the pre-Investigational New Drug (IND) process and accelerate the clinical translation of novel cell therapy products.Premier Research/BioCentriq LogoBy leveraging Premier Research's expertise in cell therapy product development and BioCentriq's proficiency in developing and manufacturing and testing cell therapies, the partnership will streamline the process of bringing new products to patients. As partners, Premier and BioCentriq are well positioned to support sponsors seeking to expedite the transition of their innovative cell therapy candidates from research to clinical trials."Partnering with BioCentriq aligns with our commitment to expediting the development of transformative cell therapies," stated Kenneth Ndugga-Kabuye, MD, FACMG, Vice President, Cell and Gene Therapy at Premier Research. "By merging our comprehensive product development expertise with BioCentriq's specialized capabilities we will help sponsors simplify the development process from pre-IND through approval, ultimately accelerating the delivery of innovative therapies to patients in need."This collaboration will harness Premier Research's comprehensive understanding of regulatory requirements, clinical trial design and study execution, alongside BioCentriq's specialized capabilities in cell therapy development."Cell therapy development is extremely complex," added Olu Aloba, PhD, Vice President, Chemical Manufacturing and Control (CMC) Services, Premier Consulting, a business unit of Premier Research, "Nonclinical and Clinical development, CMC, and the CDMO have to work hand in hand to address the scientific, logistical and regulatory demands that enable studies to generate high-quality results.""This collaboration marks a significant step in fostering a more streamlined pathway for groundbreaking cell therapies," remarked Alex Klarer, Vice President, Business Strategy and Innovation at BioCentriq. "Combining Premier Research's clinical insights with our CDMO expertise will empower us to expedite the translation of novel therapies from the lab to clinical reality, benefiting patients worldwide."About Premier ResearchPremier Research, a global clinical research, product development, and consulting company, is dedicated to helping biotech, specialty pharma, and medtech innovators transform life-changing ideas and breakthrough science into new medical treatments.Premier Research specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.Whether it's developing product lifecycle strategies, reducing clinical development cycle timelines, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions